TCL Archive Nutrition May Get An Extra 44 Million In FY 1979; Program Announcement Describes Opportunities September 22, 1978
TCL Archive Interim Analysis of Phase III Data Preferable For Accelerated Approval, FDA’s Pazdur Says September 6, 2002
TCL Archive NeoRx Suspends Accrual, Treatment In Phase III trial Using STR For Myeloma. December 1, 2000